生产企业：OPKO Health
OPK-88006 is OPKO Health's long-acting GLP-1/glucagon dual agonist peptide — a long-acting analogue of the peptide hormone oxyntomodulin, a naturally occurring GLP-1/glucagon dual agonist. In collaboration with Entera Bio, it is being advanced as an oral GLP-1/glucagon tablet candidate that combines the peptide with Entera's N-Tab oral delivery technology, targeting obesity and metabolic disorders.
OPK-88006 is OPKO Health's long-acting GLP-1/glucagon dual agonist peptide — a long-acting analogue of the peptide hormone oxyntomodulin, a naturally occurring GLP-1/glucagon dual agonist. In collaboration with Entera Bio, it is being advanced as an oral GLP-1/glucagon tablet candidate that combines the peptide with Entera's N-Tab oral delivery technology, targeting obesity and metabolic disorders.
Long-acting GLP-1/glucagon dual agonist; a long-acting analogue of the peptide hormone oxyntomodulin (a naturally occurring GLP-1/glucagon dual agonist).
